GlycanAge
An at-home finger-prick test that turns IgG glycan patterns into a biological-age report, with a 40-minute specialist interpretation call included.
- One-off
- $499
- Sample
- Finger-prick dried blood
- Results
- About 3–4 weeks
- Interpretation
- 40-minute call included
Who they are
Overview
GlycanAge is a UK testing company centered on one shipped consumer product: the GlycanAge test. Customers collect a finger-prick blood sample at home, return the dried collection card for laboratory analysis, and receive an online report covering biological age, glycan indexes, comparison data, and personalized insights.
Each core test includes a 40-minute result-interpretation call with a GlycanAge specialist. Customers can order a single test, prepay for two tests or subscribe to repeat testing.
At a glance
The practical details to understand before comparing the current offer.
- One-off
- $499
- Sample
- Finger-prick dried blood
- Results
- About 3–4 weeks
- Interpretation
- 40-minute call included
- Footprint
- ships to 65+ countries
- Consumer footprint
- At-home test · ships to 65+ countries
- Published prices
- from $424/test · $499 one-off
Company claims
Tracking lifestyle changes
GlycanAge says repeat testing can help users track whether changes in sleep, stress, hormones, training, nutrition and recovery are reflected in their biology.
Personalised health insights
GlycanAge says its report links a person's glycan profile to health areas influenced by chronic inflammation and highlights lifestyle factors to discuss with a specialist.
Cost + plan terms
Pricing and plan terms
Core test options
One-off, repeat-testing and two-test purchases.
Choose a one-off test, a repeat-testing subscription or a prepaid two-test bundle.
One-time test purchases
One-off core test
One kit, online report and a 40-minute interpretation call, with no recurring commitment
$499View core testTwo-test bundle
One-time purchase of two kits, reports and interpretation calls; the live page shows 10% off $998
$898View two-test bundle
Repeat testing · price per test
Core test · every 6 months
One test and charge every 6 months, normally two per year · 15% published subscription saving · continues until canceled
$424/testView six-month optionCore test · every 12 months
One test and charge every 12 months, with a 10% published subscription saving. Continues until canceled.
$449/testView annual option
- Subscription renewal
Core subscriptions can be cancelled in account settings. Service remains active through the current billing period, and the company says it sends a notice three days before the next scheduled test and charge.
- Two-test bundle
The one-time two-test bundle is $898. It does not create a continuing subscription.
- Payment options
GlycanAge does not offer payment plans for spreading the test cost.
- Payment currencies
Prices here are GlycanAge's published USD prices. GlycanAge accepts payment in USD, AED, GBP and EUR, and checkout sets the amount charged. A price shown in any other currency is a display estimate, not a payable price.
Services
What they offer
Self-pay · HSA/FSA funds accepted
HSA/FSA eligible in the US (badge on homepage). No traditional insurance pathway — self-pay only.
Prices checked 15 Oct 2026
Start → result
How it works
Register the kit, collect and dry the finger-prick sample, return it, then review the online result and included specialist call.
Collect and return
Collect blood on the finger-prick card, dry it for two hours, pack it with desiccant, and return it as soon as possible.
Analyze and report
The laboratory analyzes IgG glycan patterns and publishes the report online, currently in about 3–4 weeks.
Interpret and compare
Use the included 40-minute call to interpret the result, then compare a later test if longitudinal tracking is useful.
What is measured
What the test measures
GlycanAge profiles IgG N-glycan patterns and converts them into a biological-age result and related glycan indexes.
Finger-prick dried blood
Core GlycanAge testing
Available as a one-off test, an annual or six-month subscription, or a prepaid two-test bundle.
Every route uses the same assay and report; repeat options are designed for comparing results over time.
Where + how to access
Availability and access
This is a shipped test rather than a GlycanAge clinic service. Return logistics can differ by country.
- Shipping
- More than 65 countries
- Postal and blood-sample export requirements can change how the sample is returned.
- Collection
- At home by finger prick
- The sample must be registered, dried, packed and returned according to the kit instructions.
- Results
- About 3–4 weeks
- The company states this window after the sample is processed; timing can vary.
- Support
- 40-minute interpretation call
- The included call explains the report but is not treating-physician care.
Diagnostics
At home
- From $424 · per testPublished price · Price verified 2026-08-26
GlycanAge · $$$ · IgG glycan profile (single biomarker family)
Testing company · at-home biological-age test
Publicly identified team
Leadership
Publicly identified company and clinical leaders.
Co-founder and Chief Scientific Officer
Gordan Lauc
Named on the current company team page as the co-founder responsible for scientific leadership.
Co-founder and Chief Executive Officer
Nikolina Lauc
Named on the current company team page as co-founder and chief executive.
Co-founder and Chief Technology Officer
Filip Lauc
Named on the current company team page as co-founder and technology leader.
Chief Operating Officer
Zornitsa Dimitrova
Named on the current company team page for operating leadership.
Chief Product Officer
Marko Tarnaj
Named on the current company team page for product leadership.
Chief Financial Officer
Martin Iliev
Named on the current company team page for financial leadership.
Chief Marketing Officer
Vladimira Mihaylova
Named on the current company team page for marketing leadership.
Head of Education
Paula Franceković
Named on the current company team page for education leadership.
Team
Medical advisory board
Joseph Raffaele, MD
PhysioAge, New York
Andrea B. Maier, MD, PhD
NUS Centre for Healthy Longevity, Singapore
Mark Sherwood, ND
Private practice and media, Tulsa
Amy B. Killen, MD
Humanaut Health, Park City, UT
Tamsin Lewis, MBBS
Wellgevity, London
Vlatka Zoldoš, PhD
University of Zagreb (molecular biology and glycomics)
Dragan Primorac, MD, PhD
St. Catherine Specialty Hospital, Croatia
Tim Spector, MD
King's College London / ZOE
Ronald Schnaar, PhD
Johns Hopkins University
What the research shows
Evidence and limitations
Research links IgG glycan patterns with age and shows that the measurement can be repeated consistently. What a change in score means for long-term health is less certain.
What is established
Published studies report age-related IgG glycan patterns and high measurement precision. Some study authors have GlycanAge or Genos affiliations.
What remains uncertain
A lower GlycanAge score has not been shown to mean better health, improved function or a longer life. A 2026 JCI review describes remaining uncertainty about using biological-age scores to guide clinical care.
GlycanAge is an informational wellness test, not a diagnostic or treatment service. Medical concerns need clinical assessment rather than interpretation of the age score alone.
Reporting + company history
News and company history
Reviews
News coverage provides outside context, while company announcements document launches and milestones.
Independent reporting and context
Reporting provides company, market and consumer context; it is not proof that the product or service improves health outcomes.
- UK longevity startup GlycanAge raises €7,400,000 to bring glycan-based ageing diagnostics into mainstream healthcareView source
EU-Startups
Trade reporting
Checked 29 Aug 2026
- GlycanAge raises €7,400,000 to turn aging into data and detect risk before diseaseView source
ITKeyMedia
Trade reporting
Checked 29 Aug 2026
Lider Media
Independent reporting
Checked 29 Aug 2026
Forbes
Independent reporting
Checked 29 Aug 2026
News-Medical
Trade reporting
Checked 29 Aug 2026
Company and partner announcements
Company announcements document launches and milestones; they do not independently establish health benefit.
Guinness Ventures
Company or partner release
Checked 29 Aug 2026
Common questions
Frequently asked questions
Transparency
Transparency and sources
Researched by Longevity.io
- Reviewed
Company information
- Company information
- Company information
- Company information
- Company information
- Company information
- Company information
- Company information
- Terms or regulatory
- Company information
- Company information
- Primary source
- Primary source
- Primary source
- Primary source
- Primary sourceGuinness Ventures investment announcement · $8,700,000 / €7,400,000 roundView source
Independent evidence context
- Independent research
- Independent research
- Independent research
News and company history
- Trade reportingEU-Startups · UK longevity startup GlycanAge raises €7,400,000 to bring glycan-based ageing diagnostics into mainstream healthcareView source
- Trade reportingITKeyMedia · GlycanAge raises €7,400,000 to turn aging into data and detect risk before diseaseView source
- Independent reporting
- Independent reporting
- Trade reporting
- Company or partner release
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.
Keep exploring
Build your starting plan.
A few short questions, about two minutes. The Blueprint recommends where to start and explains why.
Build my Blueprint